Viatris seeks patent ruling for proposed Wegovy generic
Reuters reports that Viatris sued Novo Nordisk in Delaware federal court, seeking a ruling that its proposed generic would not violate Novo's patent rights.
TLDR
Generic drugmaker Viatris has sued Novo Nordisk over its proposed generic version of Wegovy, Novo's GLP-1 drug, Reuters reports. Viatris is asking a Delaware federal court to rule that the proposed generic would not infringe Novo's patents.
Combined views
191.4K
2 Sources, first seen ago
